Followers | 862 |
Posts | 35342 |
Boards Moderated | 21 |
Alias Born | 03/22/2016 |

Monday, January 23, 2023 8:54:04 AM
Recent INBX News
- Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results • PR Newswire (US) • 03/17/2025 08:05:00 PM
- Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer • PR Newswire (US) • 01/21/2025 10:01:00 PM
- Inhibrx Biosciences Announces Loan Agreement with Oxford Finance • PR Newswire (US) • 01/13/2025 09:15:00 PM
- Inhibrx Biosciences Reports Third Quarter 2024 Financial Results • PR Newswire (US) • 11/14/2024 09:24:00 PM
- Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation • PR Newswire (US) • 11/04/2024 09:00:00 PM
- Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights • PR Newswire (US) • 08/13/2024 10:54:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 10:21:39 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/30/2024 08:34:57 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 05/30/2024 08:32:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:13:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:55:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 10:15:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:44:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:08:28 PM
- Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi • PR Newswire (US) • 05/24/2024 08:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 01:54:07 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/21/2024 01:48:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 09:29:05 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/17/2024 08:25:28 PM
- Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off • PR Newswire (US) • 05/10/2024 10:36:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:17 PM
UAV Corp. to Present Critical Inflation Test in 30 Days, Paving the Way to Secure Over $525 Million in DART Series Sales Contracts • UMAV • Mar 14, 2025 1:00 PM
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance • FITY • Mar 14, 2025 10:30 AM
WIN-LIGHT GLOBAL FILES SEC SCHEDULE 13G DISCLOSING 1.96M SHARES OF PASSIVE INSTITUTIONAL INVESTOR OWNERSHIP • CNTM • Mar 14, 2025 7:13 AM
The Crypto Company Expands Leadership Team With Experienced Financial and Blockchain Professionals • CRCW • Mar 13, 2025 9:23 AM
ConnectM Announces $10 Million Share Repurchase Program • CNTM • Mar 13, 2025 9:13 AM
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making • SIGY • Mar 12, 2025 9:41 AM